Skip to main content

User account menu

  • Contact Us
  • Log in
Home

Main navigation

  • Home
  • Centers
  • Research Cores
  • Publications
  • Meetings
  • News
  • Funding Opportunity
  • Diabetes Resources
  • Pilot & Feasibility
  • NIDDK Centers
    • Diabetes Translation
    • Cystic Fibrosis Translation
    • Mouse Metabolic Phenotyping
    • Nutrition Obesity

Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes

Mark Davis PhD
Stanford University
2019 Pilot & Feasibility Awardee
Email
Center Stanford University
Award Year 2019
Pilot Study Targeting KIR+ Regulatory CD8+ T cells in Type 1 Diabetes
Awardee Mark Davis PhD ORCiD
Supported by grant Diabetes Research Centers (P30) from the National Institute of Diabetes and Digestive and Kidney Diseases